Edgestream Partners, L.P. Exact Sciences Corp Transaction History

Edgestream Partners, L.P.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$65.94 - $99.04 $1.06 Million - $1.6 Million	16,106 Added 106.66%	31,206 $2.13 Million
Q2 2023 Aug 10, 2023	BUY	$62.68 - $95.05 $946,468 - $1.44 Million	15,100 New	15,100 $1.42 Million
Q4 2022 Feb 13, 2023	BUY	$30.35 - $53.15 $535,343 - $937,512	17,639 New	17,639 $873,000
Q2 2022 Aug 12, 2022	BUY	$35.61 - $76.23 $1.81 Million - $3.87 Million	50,740 Added 103.25%	99,883 $3.93 Million
Q1 2022 May 13, 2022	BUY	$57.56 - $82.54 $1.7 Million - $2.44 Million	29,514 Added 150.36%	49,143 $3.44 Million
Q4 2021 Feb 15, 2022	BUY	$72.5 - $100.68 $1.42 Million - $1.98 Million	19,629 New	19,629 $1.53 Million
Q3 2021 Nov 15, 2021	SELL	$90.24 - $124.05 $3.35 Million - $4.6 Million	-37,097 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$93.66 - $139.27 $506,232 - $752,754	5,405 Added 17.05%	37,097 $4.61 Million
Q1 2021 May 06, 2021	BUY	$116.57 - $155.01 $3.69 Million - $4.91 Million	31,692 New	31,692 $4.18 Million

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Edgestream Partners, L.P., based on Form 13F filings with the SEC.

Stay updated on Edgestream Partners, L.P. with notifications on news.